Display Settings:

Format

Send to:

Choose Destination
    Cancer Res. 1992 Oct 1;52(19 Suppl):5465s-5467s.

    Primary immunodeficiencies: genetic risk factors for lymphoma.

    Source

    Immunodeficiency Cancer Registry, University of Minnesota, Minneapolis 55455.

    Abstract

    It has been estimated that up to 25% of patients with certain genetically determined immunodeficiencies will develop tumors, primarily B-cell lymphomas, during their lifetime. Epstein-Barr virus appears to be an important cofactor in the development of lymphoproliferative disorders in patients with primary immunodeficiencies, as well as acquired immunodeficiencies. Additionally, host defects in immunoregulation and/or gene rearrangement, which are features of certain primary immunodeficiencies, probably contribute to the risk of lymphomagenesis in patients at risk.

    PMID:
    1327508
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk